Sustained release formulations for the treatment of intraocular pressure or glaucoma
Abstract:
The present embodiments provide for methods of treating elevated intraocular pressure or glaucoma using a sustained release medicament consisting of prostaglandin in benzyl benzoate that is injected intraocularly no more frequently than once every two months.
Information query
Patent Agency Ranking
0/0